or Try an Advanced Search...

    Technical Analysis for RVMD - Revolution Medicines, Inc.

    Grade Last Price % Change Price Change
    F 39.96 0.33% 0.13
    RVMD closed up 0.33 percent on Wednesday, January 15, 2025, on 1.56 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical RVMD trend table...
    Date Alert Name Type % Chg
    Pocket Pivot Bullish Swing Setup 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Multiple of Ten Bearish Other 0.00%
    Gapped Up Strength 0.00%
    Below Lower BB Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish 0.33%
    180 Bearish Setup Bearish Swing Setup 0.33%
    Expansion Breakdown Bearish Swing Setup 0.33%
    Older End-of-Day Signals for RVMD ...

       Recent Intraday Alerts

    Alert Time
    Reversal New Lows Entry about 10 hours ago
    Bearish 180 Entry about 10 hours ago
    Fell Below Previous Day's Low about 10 hours ago
    Gap Up Closed about 11 hours ago
    Reversed from Up about 11 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    RVMD Chart by TradingView

    Profile

    Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Clinical Medicine Cancer Treatment Pharmacology Signal Transduction mTOR Ras Gtpase Combination Therapy

    Is RVMD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 6 Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference
    Dec 12 One Revolution Medicines Insider Raised Their Stake In The Previous Year
    Dec 5 Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
    Dec 4 Revolution Medicines: Risky Buy On Recent Share Price Dip
    Dec 4 Revolution Medicines price target raised to $87 from $82 at Guggenheim
    Dec 4 Top 3 Health Care Stocks That Could Blast Off In December
    Dec 4 Revolution Medicines prices $750M securities offering
    Dec 4 Revolution Medicines Announces Pricing of Upsized $750.0 Million Public Offering of Common Stock and Pre-Funded Warrants
    Dec 2 Revolution Medicines commences public offering of common stock
    Dec 2 Revolution Medicines Announces Commencement of Public Offering of Common Stock
    See more RVMD news...

    Comments

    Indicators

    Indicator Value
    52 Week High 62.4
    52 Week Low 25.93
    Average Volume 1,678,426
    200-Day Moving Average 43.78
    50-Day Moving Average 49.90
    20-Day Moving Average 43.49
    10-Day Moving Average 42.86
    Average True Range 1.85
    RSI (14) 29.58
    ADX 30.19
    +DI 11.69
    -DI 31.10
    Chandelier Exit (Long, 3 ATRs) 41.27
    Chandelier Exit (Short, 3 ATRs) 45.03
    Upper Bollinger Bands 46.38
    Lower Bollinger Band 40.60
    Percent B (%b) -0.11
    BandWidth 13.30
    MACD Line -2.06
    MACD Signal Line -1.96
    MACD Histogram -0.0949
    Fundamentals Value
    Market Cap 6.55 Billion
    Num Shares 164 Million
    EPS -3.26
    Price-to-Earnings (P/E) Ratio -12.26
    Price-to-Sales 192.04
    Price-to-Book 5.95
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 42.84
    Resistance 3 (R3) 43.00 42.20 42.36
    Resistance 2 (R2) 42.20 41.47 42.12 42.20
    Resistance 1 (R1) 41.08 41.01 40.68 40.92 42.04
    Pivot Point 40.28 40.28 40.08 40.20 40.28
    Support 1 (S1) 39.16 39.55 38.76 39.00 37.88
    Support 2 (S2) 38.36 39.09 38.28 37.72
    Support 3 (S3) 37.24 38.36 37.56
    Support 4 (S4) 37.08